Information: This is an outdated version of the data model. You can find a Versions overview via Versions on the left. You can find the newest Version by clicking here.
Information:
Error:
ID
34469
Description
Study of Current Practice Which Compare the Rate of Prostate Cancer by Using 2 Kind of Transrectal Biopsies: 3 by IRM-echography Image Fusion and 12 Systematized Guided Echographies.; ODM derived from: https://clinicaltrials.gov/show/NCT02050542
Link
https://clinicaltrials.gov/show/NCT02050542
Keywords
Versions (2)
- 1/17/19 1/17/19 -
- 2/11/20 2/11/20 - Christian Arras
Copyright Holder
see on clinicaltrials.gov
Uploaded on
January 17, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Prostate Cancer Based on a Rise of the PSA > 4 ng / mL. NCT02050542
Eligibility Prostate Cancer Based on a Rise of the PSA > 4 ng / mL. NCT02050542
- StudyEvent: Eligibility
Similar models
Eligibility Prostate Cancer Based on a Rise of the PSA > 4 ng / mL. NCT02050542
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
ID.1
Item
patient from 45 to 75 years old;
boolean
ID.2
Item
serum level of psa > 4,0 ng / ml;
boolean
ID.3
Item
multiparametric prostate irm, performed before inclusion and which confirm the diagnosis of suspected target;
boolean
ID.4
Item
no opposition of the patient notified in the medical record
boolean
ID.5
Item
patient member in a national insurance scheme.
boolean
ID.6
Item
previous prostate biopsy;
boolean
ID.7
Item
suspicious digital rectal examination;
boolean
ID.8
Item
serum psa > 20,0 ng / ml;
boolean
ID.9
Item
treatment with 5 alpha reductase inhibitor during the last 3 months;
boolean
ID.10
Item
untreated urinary infection
boolean